Expected earnings - GT Biopharma Inc.
Source: US Earnings Reports
GT Biopharma Inc. (GTBP) is expected to report $-0.68 for Q2 2025
GT Biopharma Inc.
NASDAQ: GTBP
GTBP Trading
37.97% G/L:
$0.44 Last:
8,878,967 Volume:
$0.374 Open:
GTBP Latest News
May 14, 2026 12:45:00 pm
First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid Tumors
May 14, 2026 10:55:00 am
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
May 14, 2026 09:15:00 am
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
GTBP Stock Data
$13,901,784
16,849,517
7.73%
17
N/A
Biotechnology & Life Sciences
Healthcare
US
San Francisco
